Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004130 | Panoply™ Human DDR2 Knockdown Stable Cell Line | Inquiry |
| CSC-SC004130 | Panoply™ Human DDR2 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT0804 | Human DDR2 Knockout Cell Line-HeLa | Inquiry |
| CLOE-1611 | Human DDR2 Insect Cell Lysate | Inquiry |
| CLOE-1613 | Human DDR2 HEK293 Cell Lysate | Inquiry |
| CLOE-1614 | Human DDR2(Fc) HEK293 Cell Lysate | Inquiry |
| CLOE-1954 | Rat Ddr2 (His) HEK293 Cell Lysate | Inquiry |
| CLOE-1959 | Rat Ddr2 (Fc) HEK293 Cell Lysate | Inquiry |
| CLOE-2630 | Mouse Ddr2 (His) HEK293 Cell Lysate | Inquiry |
| CLKO-0307 | DDR2 KO Cell Lysate-HeLa | Inquiry |
| CSC-SC004130-1 | Human DDR2 Stable Cell Line - CHO-K1 | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD04684Z | Human DDR2 adenoviral particles | Inquiry |
| LV00259Z | Human DDR2 lentiviral particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHG226497 | shRNA set against Human DDR2(NM_001014796.1) | Inquiry |
| SHG226063 | shRNA set against Human DDR2(NM_001014796.1) | Inquiry |
| SHG226439 | shRNA set against Mouse Ddr2(NM_022563.2) | Inquiry |
| SHG226457 | shRNA set against Human DDR2(NM_006182.2) | Inquiry |
| SHH275741 | shRNA set against Mouse DDR2 (NM_022563.2) | Inquiry |
| SHH275745 | shRNA set against Rat DDR2 (NM_031764.3) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCL183903 | Rat DDR2 ORF clone(NM_031764.3) | Inquiry |
| CDCR292158 | Human DDR2 ORF Clone(NM_006182.2) | Inquiry |
| CDFH004890 | Human DDR2 cDNA Clone(NM_001014796.1) | Inquiry |
| CDFH004891 | Human DDR2 cDNA Clone(NM_006182.2) | Inquiry |
| CDFH004892 | Human DDR2 cDNA Clone(NM_006182.2) | Inquiry |
| CDFR012896 | Rat Ddr2 cDNA Clone(NM_031764.3) | Inquiry |
| MiUTR1H-02718 | DDR2 miRNA 3'UTR clone | Inquiry |
| MiUTR1H-02719 | DDR2 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-03745 | DDR2 miRNA 3'UTR clone | Inquiry |
| SKO0177 | DDR2 Validated sgRNA vector | Inquiry |
| CDCB156645 | Cynomolgus DDR2 ORF clone | Inquiry |
| CDCB183740 | Rabbit DDR2 ORF clone (XM_008264156.1) | Inquiry |
| CDCL183901 | Human DDR2 ORF clone(NM_001014796.1) | Inquiry |
| CDCL183902 | Mouse DDR2 ORF clone(NM_022563.2) | Inquiry |
Discoidin structural domain receptor tyrosine kinases (DDRs) are a class of receptor tyrosine kinases (RTKs) whose dysregulation is associated with a variety of diseases, including cancer, chronic inflammation, and fibrosis. DDR family members (DDR1a-e and DDR2) are widely expressed, with DDR1 expressed predominantly in epithelial cells and DDR2 expressed predominantly in hypodermal cells. DDR2 is a member of the discoidin domain receptor family, which is characterized by the presence of a discoidin domain in their extracellular region.
Overexpression of DDR1 promotes tumor cell proliferation (including regulation of tumor-infiltrating CD4+ and CD8+ T cells), while silencing or knockdown of DDR1 reduces tumor cell growth. Overexpression of DDR1/2 in cells expressing integrins α1β1 and α2β1 increased the level of integrin activation-mediated cell adhesion. Integrin β1 promotes cell differentiation by down-regulating E-cadherin expression, whereas DDR1 promotes cell differentiation by increasing the stability of E-cadherin membrane proteins. Furthermore, deletion of either E-cadherin or DDR1 is enough to promote increased cortical contractility, which leads to loss of cell-cell adhesion. It has been shown that DDR1 and integrin α2β1 upregulate N-cadherin by interacting with transforming growth factor β-inducible protein I (TGFβI), thereby promoting growth, invasion, and metastasis. Of interest, DDR1 expression can be mediated through the secretory pathway Ca2+ -ATPase (SPCA2) via collagen I and miR-199B-5p.
DDR2 has been implicated in various pathological conditions, including tissue repair, fibrosis, and cancer. In tissue repair, DDR2 plays a crucial role in regulating fibroblast proliferation and migration, which are essential for wound healing. DDR2 knockout mice have shown delayed wound healing and impaired fibroblast function, highlighting the importance of DDR2 in tissue repair.
Extracellular matrix (ECM) interactions regulate the cellular transcriptome and proteome, thereby determining cell fate. Traumatic heterotopic ossification (HO) is a disorder characterized by abnormal differentiation of mesenchymal lineage (MLin) cells, which form bone within the soft tissues of the musculoskeletal system after trauma. Recent studies have shown that HO is affected by ECM-MLin cell receptor signaling, but how ECM binding affects cellular outcomes remains unclear. The cell surface receptor for fibrillar collagen, discoidin structural domain receptor 2 (DDR2), is a key MLin cell regulator during HO formation. DDR2 signaling is inhibited by constitutive or conditional Ddr2 deletion or pharmacological inhibition. Mechanistically, DDR2 perturbation alters focal adhesion orientation and subsequent stromal organization, regulating MLin cell signaling mediated by focal adhesion kinase (FAK) and Yes1 As- social transcriptional regulator and WW domain-containing transcriptional regulator 1 (YAP/TAZ). Thus, ECM-DDR2 interaction is a key driver of HO and may serve as an unknown therapeutic target for the treatment of HO.
References: